Jonathan F Head

Summary

Publications

  1. ncbi Stereotactic radiofrequency ablation: a minimally invasive technique for nonpalpable breast cancer in postmenopausal patients
    Jonathan F Head
    Elliott, Elliott, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, United States
    Cancer Epidemiol 33:300-5. 2009
  2. ncbi Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas
    Xian P Jiang
    Elliott Elliott Head Breast Cancer Research and Treatment Center, 17050 Medical Center Drive, 4th Floor, Baton Rouge, LA 70816, USA
    Anticancer Res 30:759-65. 2010
  3. ncbi Gene targets of antisense therapies in breast cancer
    Ding Cheng Yang
    Mastology Research Institute, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Expert Opin Ther Targets 6:375-85. 2002
  4. ncbi Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo
    Xian P Jiang
    Mastology Research Institute, Elliott-Hailey-Head Breast Cancer Research and Treatment Center, 17050 Medical Center Drive, 4th Floor, Baton Rouge, LA 70816, USA
    Anticancer Res 22:2685-92. 2002
  5. ncbi Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells
    Xian Peng Jiang
    Mastology Research Institute, Elliott Ellott Head Breast Cancer Research and Treatment Center, 17050 Medical Center Drive, 4th Floor, Baton Rouge, LA 70816, USA
    Anticancer Res 31:2899-906. 2011
  6. ncbi Human leukocyte antigen G expression in breast cancer: role in immunosuppression
    Robert L Elliott
    Elliott Elliott Head Breast Cancer Research and Treatment Center, Baton Rouge, Louisiana 70816, USA
    Cancer Biother Radiopharm 26:153-7. 2011
  7. ncbi Complete resolution of malignant ascites in stage IV breast cancer by peritoneal drainage and innovative chemoimmunotherapy: a case report
    Robert L Elliott
    Elliott, Elliott, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Cancer Biother Radiopharm 21:138-45. 2006
  8. ncbi Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells
    Ding Cheng Yang
    Mastology Research Institute of The E.H.H. Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Anticancer Res 22:1513-24. 2002

Collaborators

Detail Information

Publications8

  1. ncbi Stereotactic radiofrequency ablation: a minimally invasive technique for nonpalpable breast cancer in postmenopausal patients
    Jonathan F Head
    Elliott, Elliott, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, United States
    Cancer Epidemiol 33:300-5. 2009
    ..The purpose of this study was to determine the feasibility of radiofrequency ablation (RFA) of nonpalpable breast cancer in postmenopausal women, and report on long-term follow-up with clinical examination and mammography...
  2. ncbi Manipulation of iron transporter genes results in the suppression of human and mouse mammary adenocarcinomas
    Xian P Jiang
    Elliott Elliott Head Breast Cancer Research and Treatment Center, 17050 Medical Center Drive, 4th Floor, Baton Rouge, LA 70816, USA
    Anticancer Res 30:759-65. 2010
    ..Suppression of transferrin receptor by antisense results in inhibition of tumor growth and lung metastasis in the 4T1 mammary adenocarcinoma mouse model...
  3. ncbi Gene targets of antisense therapies in breast cancer
    Ding Cheng Yang
    Mastology Research Institute, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Expert Opin Ther Targets 6:375-85. 2002
    ..However, in order to determine their feasibility antisense therapies need to be further investigated to determine their antitumour activity, pharmacokinetics and toxicity in breast cancer patients...
  4. ncbi Induction of apoptosis by iron depletion in the human breast cancer MCF-7 cell line and the 13762NF rat mammary adenocarcinoma in vivo
    Xian P Jiang
    Mastology Research Institute, Elliott-Hailey-Head Breast Cancer Research and Treatment Center, 17050 Medical Center Drive, 4th Floor, Baton Rouge, LA 70816, USA
    Anticancer Res 22:2685-92. 2002
    ..05 and p < 0.01, respectively, Student's t-test). This is the first report of iron depletion caused by a low iron diet or deferoxamine mesylate treatment inducing apoptosis in rats bearing the 13762NF marnmary adenocarcinoma...
  5. ncbi Down-regulation of expression of interleukin-6 and its receptor results in growth inhibition of MCF-7 breast cancer cells
    Xian Peng Jiang
    Mastology Research Institute, Elliott Ellott Head Breast Cancer Research and Treatment Center, 17050 Medical Center Drive, 4th Floor, Baton Rouge, LA 70816, USA
    Anticancer Res 31:2899-906. 2011
    ..In conclusion, IL-6 plays an important role in maintaining the growth of MCF-7 breast cancer cells. These results suggest careful modulation of IL-6 and IL-6R expression of cells as a potential approach for breast cancer therapy...
  6. ncbi Human leukocyte antigen G expression in breast cancer: role in immunosuppression
    Robert L Elliott
    Elliott Elliott Head Breast Cancer Research and Treatment Center, Baton Rouge, Louisiana 70816, USA
    Cancer Biother Radiopharm 26:153-7. 2011
    ..05). HLA-G staining was found in the membranes and cytoplasm of cancer cells. In conclusion, breast cancer cells overexpress HLA-G mRNA and protein, and this probably contributes to immune evasion...
  7. ncbi Complete resolution of malignant ascites in stage IV breast cancer by peritoneal drainage and innovative chemoimmunotherapy: a case report
    Robert L Elliott
    Elliott, Elliott, Head Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Cancer Biother Radiopharm 21:138-45. 2006
    ..We are reporting a case of complete remission of malignant ascites in a stage IV breast cancer patient. Her condition was managed by a peritoneal dialysis catheter and an aggressive intraperitoneal innovative chemoimmunotherapy protocol...
  8. ncbi Antisense ferritin oligonucleotides inhibit growth and induce apoptosis in human breast carcinoma cells
    Ding Cheng Yang
    Mastology Research Institute of The E.H.H. Breast Cancer Research and Treatment Center, Baton Rouge, LA 70816, USA
    Anticancer Res 22:1513-24. 2002
    ....